2008
DOI: 10.1038/leu.2008.252
|View full text |Cite
|
Sign up to set email alerts
|

Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
25
1

Year Published

2009
2009
2018
2018

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 27 publications
(37 citation statements)
references
References 8 publications
3
25
1
Order By: Relevance
“…Other groups confirmed an improvement of the aberration detection rate in CpG/IL-2 (i.e. an increase of 9-13% of cases with aberrations) compared with TPA stimulated cultures (Put et al, 2009a;Struski et al, 2009). Moreover, the detection of translocations and del(13q) in particular, has been found to be superior after CpG/IL-2 stimulation compared with TPA (Put et al, 2009a).…”
Section: Dsp30supporting
confidence: 63%
See 3 more Smart Citations
“…Other groups confirmed an improvement of the aberration detection rate in CpG/IL-2 (i.e. an increase of 9-13% of cases with aberrations) compared with TPA stimulated cultures (Put et al, 2009a;Struski et al, 2009). Moreover, the detection of translocations and del(13q) in particular, has been found to be superior after CpG/IL-2 stimulation compared with TPA (Put et al, 2009a).…”
Section: Dsp30supporting
confidence: 63%
“…The addition of the cytokine IL-2 to TPA stimulated CLL cell cultures was reported to directly stimulate CLL proliferation, even in absence of T-lymphocytes (Touw and Lowenberg, 1985). Although the latter findings provide evidence for the addition of IL-2 to TPA cultures, it is not mandatory for successful CCA (Put et al, 2009a;Struski et al, 2009). …”
Section: Tpamentioning
confidence: 90%
See 2 more Smart Citations
“…For proliferation assay, cells were labeled with 1 mM of carboxyfluorescein succinimidyl ester (Invitrogen, Cergy Pontoise, France) at 37 1C during 10 min and were subsequently treated or not with 250 nM of DSP30 (CpG-ODN) (Sequence: 5 0 -TCGTCGCTGTCTCCGCTTCTTCTTGCC-3 0 ) (TIB MOLBIOL, Berlin, Germany) in combination with 50 ng/ml of recombinant glycosylated interleukin (IL)-2 (kind gift from SanofiAventis, Toulouse, France) in RPMI containing 10% fetal calf serum during 7 days. 23,24 Flow cytometry…”
Section: B-cll Samples and Culturementioning
confidence: 99%